Iacovelli, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 289
EU - Europa 240
AS - Asia 118
AF - Africa 4
Totale 651
Nazione #
US - Stati Uniti d'America 286
SE - Svezia 120
SG - Singapore 46
IT - Italia 44
CN - Cina 42
IE - Irlanda 27
ID - Indonesia 18
DE - Germania 15
FR - Francia 11
IN - India 7
RU - Federazione Russa 7
CI - Costa d'Avorio 4
CA - Canada 3
GB - Regno Unito 3
UA - Ucraina 3
FI - Finlandia 2
HK - Hong Kong 2
AT - Austria 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
LT - Lituania 1
LU - Lussemburgo 1
NL - Olanda 1
PT - Portogallo 1
Totale 651
Città #
Chandler 81
Singapore 39
Ashburn 34
Dublin 27
Jakarta 18
Princeton 11
Beijing 8
Milan 8
New York 8
Rome 8
Boston 7
San Mateo 7
Wilmington 7
Dearborn 6
Los Angeles 6
Nanjing 5
Abidjan 4
Hebei 4
Messina 4
Moscow 4
Munich 4
Boardman 3
Jiaxing 3
Redwood City 3
Augusta 2
Bareggio 2
Bremen 2
Brescia 2
Cattolica 2
Duncan 2
Edinburgh 2
Fairfield 2
Helsinki 2
Hong Kong 2
Marseille 2
Nanchang 2
Norwalk 2
Ottawa 2
Pune 2
Redmond 2
Salerno 2
Stamford 2
Andover 1
Arlington 1
Bishkek 1
Brdo 1
Changteh 1
Chicago 1
Chuzhou 1
Clearwater 1
Cologne 1
Dalian 1
Frankfurt am Main 1
Genova 1
Glendale 1
Gunzenhausen 1
Houston 1
Leeds 1
Lisbon 1
Luxembourg 1
Madrid 1
Mountain View 1
Reggio Nell'emilia 1
Seattle 1
Tianjin 1
Tokyo 1
Toronto 1
Tres 1
Vibo Valentia 1
Vienna 1
Washington 1
Wuhan 1
Zhengzhou 1
Totale 376
Nome #
Methylation study of the Paris system for reporting urinary (TPS) categories 55
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 55
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 54
Biomarkers of response to advanced prostate cancer therapy 54
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 53
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 49
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 48
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients 46
The effect of a treatment delay on outcome in metastatic renal cell carcinoma 46
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma 43
Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer 41
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 34
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 25
Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives 22
Revising PTEN in the era of immunotherapy: New perspectives for an old story 19
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 13
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 11
Patients with sarcomatoid renal cell carcinoma – re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors 5
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study 5
Totale 678
Categoria #
all - tutte 4.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 1 11 1 1 0 12 0
2020/20219 1 0 0 0 1 0 0 1 1 0 5 0
2021/202286 6 0 3 13 10 0 2 11 3 4 23 11
2022/2023258 54 42 13 25 30 14 17 19 26 2 10 6
2023/2024177 11 36 9 22 5 22 13 1 7 12 17 22
2024/202589 6 4 33 10 18 18 0 0 0 0 0 0
Totale 678